Arş. Gör. HASAN SATIŞ

Yayın Ağı

Makaleler 54

1. Frequency of sarcopenia in Turkish women with systemic lupus erythematosus

BİLİCİ SALMAN R., Candemir B., SATIŞ H., ALP G. T., YILDIRIM BORAZAN F., Deniz O., et al.

LUPUS SCIENCE & MEDICINE , cilt.11, sa.1, 2024 (SCI-Expanded, Scopus)

2. The role of rheumatologist in the assessment of hemophilic arthropathy using head-us in patients with hemophilia

Yılmaz E., Kaya Z., Satış H., Yazol M., Kirkiz S., Koçak Ü.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.27, sa.4, 2024 (SCI-Expanded, Scopus)

3. Dynamic capacity planning of hospital resources under COVID-19 uncertainty using approximate dynamic programming

Gokalp E., Cakir M. S., SATIŞ H.

JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY , cilt.75, sa.1, ss.13-25, 2024 (SCI-Expanded, SSCI, Scopus)

4. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease

AVANOĞLU GÜLER A., YÜCE İNEL T., KAŞİFOĞLU T., COŞKUN C., KARADENİZ H., YILDIRIM D., et al.

MODERN RHEUMATOLOGY , cilt.33, ss.786-791, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjogren's syndrome

KARADENİZ H., CERİT M. N., AVANOĞLU GÜLER A., BİLİCİ SALMAN R., SATIŞ H., YILDIRIM D., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.6, ss.1083-1090, 2023 (SCI-Expanded, Scopus)

6. Sleep quality and its associations with disease activity and quality of life in older patients with rheumatoid arthritis

Deniz O., Cavusoglu C., SATIŞ H., AKIN B., Varan O., Atas N., et al.

EUROPEAN GERIATRIC MEDICINE , cilt.14, sa.2, ss.317-324, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Exocrine pancreatic dysfunction in systemic sclerosis and primary Sjogren’s syndrome patients

SATIŞ H., SALMAN R. B., BABAOĞLU H., ATAŞ N., GÜLER A. A., KARADENİZ H., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.1, ss.1-5, 2023 (Scopus, TRDizin)

8. Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'

SATIŞ H., AYDEMİR E., İZMİRLİOĞLU K., TUFAN A.

Annals of the rheumatic diseases , cilt.81, sa.12, 2022 (SCI-Expanded, Scopus)

9. Effectiveness and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

KALYONCU U., BİLGİN E., Erden A., SATIŞ H., TUFAN A., Tekgöz E., et al.

Clinical and Experimental Rheumatology , cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)

10. Diagnostic utility of serum biomarkers in large vessel vasculitis and their correlation with positron emission tomography

Salman R. B., Koca G., Ates S., Yapar D., Babaoglu H., Satis H., et al.

MODERN RHEUMATOLOGY , cilt.32, sa.5, ss.938-945, 2022 (SCI-Expanded, Scopus)

11. SERUM INTERLEUKIN 37 LEVELS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS AND ASSOCIATION WITH CLINICAL FEATURES

Fincan A., KAVUTÇU M., Atas N., Babaoglu H., Salman R. B., Satis H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1765, 2022 (SCI-Expanded, Scopus)

12. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis

Atas N., Cakir B., BAKIR F., UÇAR M., SATIŞ H., Guz G. T., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1381-1389, 2022 (SCI-Expanded, Scopus)

13. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis

KARADENİZ H., AVANOĞLU GÜLER A., KOCA G., BİLİCİ SALMAN R., SATIŞ H., Atas N., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.4, ss.1169-1176, 2022 (SCI-Expanded, Scopus)

14. Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors

BİLİCİ SALMAN R., Babaoglu H., SATIŞ H., YAPAR D., AVANOĞLU GÜLER A., KARADENİZ H., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.28, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

15. Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists

Suticen E., Atas N., AVANOĞLU GÜLER A., AKDOĞAN O., Babaoglu H., SATIŞ H., et al.

CLINICAL RHEUMATOLOGY , cilt.40, sa.7, ss.2865-2871, 2021 (SCI-Expanded, Scopus)

16. LUPUS DISEASE ACTIVITY CORRELATES WITH QUALITY OF LIFE BUT NOT WITH HEALTH LITERACY STATUS

Eraslan E., Salman R. B., Satis H., Guler A. A., Karadeniz H., KÜÇÜK H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1176, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. CLINICAL FEATURES AND THE COURSE OF COVID-19 IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

Guler A. A., Inel T. Y., Karadeniz H., Salman R. B., Satis H., KÜÇÜK H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.878-879, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. THE IMPACT OF TUMOUR NECROSIS FACTOR-ALPHA INHIBITOR TREATMENT ON WNT SIGNALING INHIBITORS, NOGGIN AND CYTOKINE LEVELS IN AXIAL SPONDYLOARTHRITIS

Atas N., Cakir B., Bakir F., Ucar M., Satis H., Guz G. T., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.733, 2021 (SCI-Expanded, Scopus)

19. TOFACITINIB IN RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: EFFICACY AND SAFETY ANALYSIS FROM TREASURE REAL-LIFE DATA

Kalyoncu U., Bilgin E., Erden A., Satis H., Tufan A., Tekgoz E., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.69-70, 2021 (SCI-Expanded, Scopus)

20. DIAGNOSTIC ACCURACY OF SERUM MARKERS IN LARGE VESSEL VASCULITIS AND CORRELATION WITH PET IMAGING

Salman R. B., Satis H., Guler A. A., KARADENİZ H., KÜÇÜK H., HAZNEDAROĞLU Ş., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.80, ss.1077, 2021 (SCI-Expanded, Scopus)

21. Response to Anakinra in 3 Patients With Erosive Osteoarthritis

Varan O., Babaoglu H., Atas N., SATIŞ H., BİLİCİ SALMAN R., TUFAN A., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.27, sa.2, 2021 (SCI-Expanded, Scopus)

22. Folfirinox versus gemcitabine-cisplatin combination as first-line therapy in treatment of pancreaticobiliary cancer

Kayahan N., Karaca M., SATIŞ H., YAPAR D., ÖZET A.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1727-1732, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

23. Successful treatment of coronary artery aneurysm with infliximab in a Behcet's disease patient

Satış H., Cindil E., Atas N., Salman R. B., Tufan A.

RHEUMATOLOGY , cilt.60, 2021 (SCI-Expanded, Scopus)

24. Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients

Atas N., Eroglu G. A., Sodan H. N., Ozturk B. O., Babaoglu H., Satis H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.39, sa.5, 2021 (SCI-Expanded, Scopus)

25. Phenotypic characterization of Familial Mediterranean Fever patients harboring variants of uncertain significance

Sari A., BODAKÇİ E., Armagan B., SATIŞ H., Atas N., YAŞAR BİLGE N. Ş., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1695-1701, 2021 (SCI-Expanded, Scopus, TRDizin)

26. Appendectomy history is associated with severe disease and colchicine resistance in adult familial Mediterranean fever patients

BODAKÇİ E., YAŞAR BİLGE N. Ş., AtaS N., Armagan B., SATIŞ H., Sari A., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.4, ss.1706-1711, 2021 (SCI-Expanded, Scopus, TRDizin)

27. Predictors of persistent inflammation in familial Mediterranean fever and association with damage

Babaoglu H., Armagan B., BODAKÇİ E., SATIŞ H., Atas N., Sari A., et al.

RHEUMATOLOGY , cilt.60, sa.1, ss.333-339, 2021 (SCI-Expanded, Scopus)

28. Comment on: Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: a 10-year study of the national inpatient sample

Satis H., Kayahan N., Babaoglu H., Akdogan O., YAPAR D.

RHEUMATOLOGY , cilt.59, sa.12, 2020 (SCI-Expanded, Scopus)

29. Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren's syndrome?

Satış H., Cindil E., Salman R. B., Yapar D., Demir N. B., Temel E., et al.

Clinical rheumatology , cilt.39, sa.12, ss.3707-3713, 2020 (SCI-Expanded, Scopus)

30. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

SATIŞ H., Oruc A., Avcu A., KARADENİZ H., AVANOĞLU GÜLER A., Kayahan N.

RHEUMATOLOGY , cilt.59, sa.8, ss.2180, 2020 (SCI-Expanded, Scopus)

31. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

SATIŞ H., Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., YILDIZ Ş., Kayahan N.

ANNALS OF THE RHEUMATIC DISEASES , cilt.79, sa.8, 2020 (SCI-Expanded, Scopus)

32. Use of prognostic nutritional index in the evaluation of disease activity in patients with Behçet’xxs disease

ATAŞ N., BABAOĞLU H., DEMİREL E., Celik B., Salman R., SATIŞ H., et al.

European Journal of Rheumatology , cilt.7, sa.3, ss.99-104, 2020 (ESCI, TRDizin)

33. Use of prognostic nutritional index in the evaluation of disease activity in patients with Behcet's disease

Atas N., Babaoglu H., Demirel E., ÇELİK B., Salman R. B., SATIŞ H., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.7, sa.3, ss.99-104, 2020 (ESCI, TRDizin)

34. Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren's syndrome.

Satış H., Cindil E., Salman R. B., Yapar D., Ülgen Temel E., Demir N. B., et al.

Lupus , cilt.29, sa.7, ss.715-720, 2020 (SCI-Expanded, Scopus)

35. Inter-rater reliability of modified hand mobility in scleroderma test

TORE N. G., SARİ F., Sarac D. C., Yentur S. B., SATIŞ H., AVANOĞLU GÜLER A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.203-206, 2020 (SCI-Expanded, Scopus)

36. Familial Mediterranean fever-associated infertility and underlying factors

Atas N., Armagan B., Bodakci E., SATIŞ H., Sari A., Bilge N. S. Y., et al.

CLINICAL RHEUMATOLOGY , cilt.39, sa.1, ss.255-261, 2020 (SCI-Expanded, Scopus)

37. Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients A Single-Center Real-Life Study

Babaoglu H., Varan O., Kucuk H., Atas N., SATIŞ H., Salman R., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.26, sa.1, ss.7-13, 2020 (SCI-Expanded, Scopus)

38. Colchicine intolerance in FMF patients and primary obstacles for optimal dosing

SATIŞ H., Armagan B., Bodakci E., Atas N., Sari A., Yasar Bilge N. S., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.5, ss.1337-1343, 2020 (SCI-Expanded, Scopus, TRDizin)

39. Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review

KARADENİZ H., AVANOĞLU GÜLER A., Atas N., SATIŞ H., Salman R. B., Babaoglu H., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.1, ss.169-173, 2020 (SCI-Expanded, Scopus)

40. Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study

Atas N., Armagan B., Bodakci E., SATIŞ H., Sari A., Bilge N. S. Y., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.1, ss.41-48, 2020 (SCI-Expanded, Scopus)

41. Tofacitinib for the Treatment of Refractory Polymyositis

Babaoglu H., Varan O., Atas N., SATIŞ H., Salman R., TUFAN A.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.25, sa.8, 2019 (SCI-Expanded, Scopus)

42. Comment on: Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit?

SATIŞ H., Senkalfa A., KARADENİZ H., AVANOĞLU GÜLER A., Salman R. B., Kayahan N., et al.

RHEUMATOLOGY , cilt.58, sa.10, ss.1886, 2019 (SCI-Expanded, Scopus)

43. Certolizumab Pegol Treatment in Three Patients With Takayasu Arteritis

Atas N., Varan O., Babaoglu H., SATIŞ H., Bilici Salman R., TUFAN A.

ARCHIVES OF RHEUMATOLOGY , cilt.34, sa.3, ss.357-362, 2019 (SCI-Expanded, Scopus, TRDizin)

44. Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

SATIŞ H., Can G. E., Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., TUFAN A.

RHEUMATOLOGY , cilt.58, sa.8, ss.1509-1510, 2019 (SCI-Expanded, Scopus)

45. The MEFV variants in patients with familial Mediterranean fever and their clinical correlations

VARAN Ö., KÜÇÜK H., BABAOĞLU H., ATAŞ N., Salman r. b., SATIŞ H., et al.

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , cilt.52, sa.2, ss.162-166, 2019 (TRDizin)

46. Detection of Familial Mediterranean Fever attacks by using a connected activity tracker and assessment of impact of attacks to daily physical activities: a pilot study

Babaoglu H., Varan O., Atas N., SATIŞ H., Salman R., ÖZTÜRK M. A., et al.

CLINICAL RHEUMATOLOGY , cilt.38, sa.7, ss.1941-1946, 2019 (SCI-Expanded, Scopus)

47. Work productivity in patients with Behcet disease and its association with disease activity and quality of life

Atas N., Varan O., Babaoglu H., SATIŞ H., Salman R. B., ÇELİK B., et al.

BRITISH JOURNAL OF OCCUPATIONAL THERAPY , cilt.82, sa.6, ss.376-382, 2019 (SCI-Expanded, SSCI, Scopus)

48. Effect of interleukin-1 antagonists on the quality of life in familial Mediterranean fever patients

Varan O., Kucuk H., Babaoglu H., Atas N., Salman R. B., SATIŞ H., et al.

CLINICAL RHEUMATOLOGY , cilt.38, sa.4, ss.1125-1130, 2019 (SCI-Expanded, Scopus)

49. On demand use of anakinra for attacks of familial Mediterranean fever (FMF)

Babaoglu H., Varan O., Kucuk H., Atas N., SATIŞ H., Salman R., et al.

CLINICAL RHEUMATOLOGY , cilt.38, sa.2, ss.577-581, 2019 (SCI-Expanded, Scopus)

50. Treatment of deep vein thrombosis in a patient with Behcet syndrome using ultrasound-accelerated catheter-directed thrombolysis

Atas N., Varan O., Babaoglu H., Salman R. B., SATIŞ H., ÖZER A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.12, ss.2193-2194, 2018 (SCI-Expanded, Scopus)

51. Activity Tracker Bracelets Captures Familial Mediterranean Fever Attacks and Their Impact on Daily Physical Activities

Babaoglu H., Varan O., Atas N., SATIŞ H., Salman R., ÖZTÜRK M. A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

52. Familial Mediterranean Fever Associated Infertility and Underlying Factors with Fertility

Atas N., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Sari A., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

53. Familial Mediterranean Fever Related Damage Assessed By Auto-Inflammatory Disease Damage Index (ADDI) and Associated Factors with Damage

TUFAN A., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Atas N., et al.

ARTHRITIS & RHEUMATOLOGY , cilt.70, 2018 (SCI-Expanded, Scopus)

54. Relatinship Between Insulin Resistance, Diabetes Mellitus and Obesity of Gut Microbiata

YETKİN İ., KAYAHAN SATIŞ N., SATIŞ H.

Turkish Journal of Diabetes and Obesity , cilt.2, sa.1, 2018 (TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 35

1. Bağ dokusu ilişkili intertisyel akciğer hastalığındasiklofosfamid tedavisi sonrası idame tedavisi:Mikofenolat mofetil ile azatiyoprinin karşılaştırılması

SATIŞ H., onut m., bilici salman r., BABAOĞLU H., ATAŞ N., AVANOĞLU GÜLER A., et al.

Ulusal romatoloji kongresi, Türkiye, 17 - 22 Ekim 2020, (Tam Metin Bildiri)

2. Ailevi Akdeniz ateşi hastalarında anakinra tedavisinin uzun dönem güvenlik ve etkinliğinin değerlendirilmesi

ATAŞ N., ATBİNER EROĞLU G., SODAN H. N., ÖZTÜRK B. O., BABAOĞLU H., Salman r. b., et al.

TRD 2020 ULUSAL ROMATOLOJİ BULUŞMASI, Türkiye, 12 - 17 Ekim 2020, (Özet Bildiri)

3. Yaşlı ankilozan spondilit hastalarında kırık riski ve ilişkili faktörler

ATAŞ N., CANDEMİR B., MURAT T., KARADENİZ H., Guler A. A., BABAOĞLU H., et al.

TRD 2020 ULUSAL ROMATOLOJİ BULUŞMASI, Türkiye, 12 - 17 Ekim 2020, (Özet Bildiri)

4. Familial Mediterranean Fever Related Damage Assessed By Auto-Inammatory Disease Damage Index (ADDI) and Associated Factors with Damage

TUFAN A., Armagan B., Bodakci E., Kasifoglu T., SATIŞ H., ATAŞ N., et al.

ACR/ARP Annual Meeting 2018, 19 Ekim 2108 - 24 Ekim 2018, (Özet Bildiri)

5. PS-074 Behçet hastalığında anti TNF tedavisi ile ilişkili paradoksik palmoplantar psöriyaziste azatioprin etkinliği

KARADENİZ H., ATAŞ N., Guler A. A., BABAOĞLU H., SATIŞ H., Salman r. b., et al.

XX. Ulusal Romatoloji Kongresi, Türkiye, 16 Ekim 2019 - 20 Ekim 2010, (Özet Bildiri)

6. FMF hastalarında kolşisin intoleransı ve optimal doz içinprimer engeller

SATIŞ H., Armagan B., Bodakci E., ATAŞ N., SARI A., YAŞAR BİLGE N. Ş., et al.

XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.71, (Özet Bildiri)

7. PS-029 FMF hastalarında kolşisin intoleransı ve optimal doz için primer engeller

SATIŞ H., Armagan B., Bodakci E., ATAŞ N., Sari A., Bilge N. S., et al.

XX. Ulusal Romatoloji Kongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

8. PS-073 Psikoz ile prezente olan nöro-Behçet vakasında 18F-FDG PET/MR ile tanı konulması

Guler A. A., ATAŞ N., KARADENİZ H., SATIŞ H., Salman r. b., BABAOĞLU H., et al.

XX. Ulusal Romatoloji Kongresi, Türkiye, 16 - 20 Ekim 2019, (Özet Bildiri)

9. Ailesel Akdeniz ateşi hastalarında kronik inflamasyon belirleyicileri ve kronik inflamasyonun hasar ile ilişkisi

BABAOĞLU H., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., ATAŞ N., et al.

XX. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 16 - 20 Ekim 2019, cilt.11, ss.65-66, (Özet Bildiri)

10. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

SATIŞ H., DEMİR B. N., BİLİCİ SALMAN R., TEMEL E., BABAOĞLU H., ATAŞ N., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY, Madrid, İspanya, 12 - 15 Haziran 2019, (Tam Metin Bildiri)

11. FREQUENCY, CHARACTERISTICS AND CLINICAL DETERMINANTS OF "PRODROME" IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

Babaoglu H., Atas N., Varan O., SATIŞ H., Salman R. B., AVANOĞLU GÜLER A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.585, (Özet Bildiri)

12. APPLICATION OF AUTO-INFLAMMATORY DISEASE DAMAGE INDEX (ADDI) TO PATIENTS WITH FMF AND RELATED FACTORS WITH DAMAGE

Babaoglu H., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1005, (Özet Bildiri)

13. PREVALENCE, UNDERLYING FACTORS AND DAMAGE ASSOCIATED WITH CHRONIC PERSISTENT INFLAMMATION IN PATIENTS WITH FMF

Babaoglu H., Armagan B., Bodakci E., KAŞİFOĞLU T., SATIŞ H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.571-572, (Özet Bildiri)

14. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME

SATIŞ H., Demir B. N., Salman R. B., ÜLGEN TEMEL E., Babaoglu H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1740, (Özet Bildiri)

15. DIAGNOSTIC UTILITY OF POSITRON EMISSION TOMOGRAPHY FOR THE EVALUATION OF PATIENTS WITH INFLAMMATION OF UNKNOWN ORIGIN

Salman R. B., Gulbahar S., SATIŞ H., Atas N., Babaoglu H., KARADENİZ H., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1360-1361, (Özet Bildiri)